The following is a searchable and filterable list of our news posts, press releases, white papers, articles, scientific posters, and much more.
If you can’t find something, please let us know and we’ll reach out to you as soon as we can.
Daten töten. Den Krebs.
An article by Friedrich von Bohlen in FOCUS Die Welt in 2023 (in German)Download articleOvercoming IVDR Challenges – A Webinar on November 8, 2022, at 18:00 CET
On-demand webinarRead moreWebinar: Deepen your knowledge on comprehensive genomic profiling
On-demand webinarRead moreMolecular Health receives IVDR certification for MH Guide
Press release, 13 July 2022Read moreMH Guide Webinar – 07.06.2022 12:00 am EST
On-demand webinarRead moreMH Guide 5.2 – Improved focus. Greater flexibility. Better usability.
Release of MH Guide upgradeRead moreMH Guide Webinar – 28.04.2022 5:00 pm CET
On-demand webinarRead moreMolecular Health and collaborators prove new analytical approach that leverages real-world data to anticipate molecular causation of adverse drug reactions
Press release, 10 March 2022Read moreWhat’s new in MH Guide 5.1
Release of MH Guide upgradeRead moreDiscover the benefits of automated variant annotation for your clinical routine
MH Guide interprets complex genetic data quickly and accurately – for the growing challenges of today and tomorrowRead moreApplication of a patient-centered reverse translational systems-based approach to understand mechanisms of an adverse drug reaction of immune checkpoint inhibitors
Kim, S. et al. Clin Transl Sci. 2022 Jun;15(6):1430-1438. doi: 10.1111/cts.13254Open resourceEvaluation of the TruSight Tumor 170 Assay and Its Value in Clinical Diagnostics
Heydt, C. et al. J. Mol. Pathol. 2022, 3(1), 53-67; https://doi.org/10.3390/jmp3010006Open resourceWhole patient knowledge modeling of COVID-19 symptomatology reveals common molecular mechanisms
Brock, S. et al. Front. Mol. Med. 2022, 2:1035290. https://doi.org/10.3389/fmmed.2022.1035290Open resourceThe COVID-19 explorer – An integrated, whole patient knowledge model of COVID-19 disease
Brock, S. et al. Front. Mol. Med. 2022, 2:1035215. https://doi.org/10.3389/fmmed.2022.1035215Open resourceThe earlier, the better – turning data into knowledge
Predisposition analyses of hereditary cancersRead more基因治療計畫的先驅
MH Guide 能夠解讀複雜的分子學分析結果， 協助您為癌症患者提供基於實證的治療建議Read moreGenome-guided treatment decision support for clinical routines
MH Guide Factsheet: From sequencing data to patient report within minutesRead moreUnlocking patient care and therapy breakthroughs from biomedical knowledge
Corporate Factsheet: We make precision medicine a reality for therapy developers, clinicians, and ultimately patientsRead morePathfinder for genome-based therapy planning
MH Guide interprets complex molecular analyses and helps you recommend evidence-based treatments for your cancer patients.Read moreA case study of a patient-centered reverse translational systems-based approach to understand adverse event profiles in drug development
Kim, S. et al. Clin Transl Sci . 2022 Apr;15(4):1003-1013. doi: 10.1111/cts.13219Open resourceAdvancing drug safety science by integrating molecular knowledge with post‐marketing adverse event reports
Soldatos, T. G. et al. CPT Pharmacometrics Syst Pharmacol. 2022 May;11(5):540-555. doi: 10.1002/psp4.12765Open resource